1. Arnold, M, Abnet, CC, Neale, RE, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. 2020;159:335-349.e15. doi:10.1053/j.gastro.2020.02.068
Google Scholar | Crossref | Medline2. Chen, C, Di Bartolomeo, M, Corallo, S, Strickler, JH, Goyal, L. Overcoming resistance to targeted therapies in gastrointestinal cancers: progress to date and progress to come. Am Soc Clin Oncol Educ Book. 2020;40:161-173. doi:10.1200/EDBK_280871
Google Scholar | Crossref3. VanderVeen, BN, Sougiannis, AT, Velazquez, KT, Carson, JA, Fan, D, Murphy, EA. The acute effects of 5 fluorouracil on skeletal muscle resident and infiltrating immune cells in mice. Front Physiol. 2020;11:593468. doi:10.3389/fphys.2020.593468
Google Scholar | Crossref4. Sougiannis, AT, VanderVeen, BN, Enos, RT, et al. Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota. Brain Behav Immun. 2019;80:44-55. doi:10.1016/j.bbi.2019.02.020
Google Scholar | Crossref | Medline5. Hu, N, Liu, J, Xue, X, Li, Y. The effect of emodin on liver disease: comprehensive advances in molecular mechanisms. Eur J Pharmacol. 2020;882:173269. doi:10.1016/j.ejphar.2020.173269
Google Scholar | Crossref6. Iwanowycz, S, Wang, J, Hodge, J, Wang, Y, Yu, F, Fan, D. Emodin inhibits breast cancer growth by blocking the tumor-promoting feedforward loop between cancer cells and macrophages. Mol Cancer Ther. 2016;15:1931-1942. doi:10.1158/1535-7163.MCT-15-0987
Google Scholar | Crossref | Medline7. Phillips, E, France, A, Thatvihane, G, Nnaemeka, U, Zaidi, S. Mucositis and cardiotoxicity due to 5-fluorouracil. Am J Ther. 2018;25:e712-e714. doi:10.1097/MJT.0000000000000725
Google Scholar | Crossref | Medline8. Sougiannis, AT, VanderVeen, BN, Davis, JM, Fan, D, Murphy, EA. Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience. Am J Physiol Gastrointest Liver Physiol. 2021;320:G712-G719. doi:10.1152/ajpgi.00380.2020
Google Scholar | Crossref | Medline9. Gezici, S, Şekeroğlu, N. Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anticancer Agents Med Chem. 2019;19:101-111. doi:10.2174/1871520619666181224121004
Google Scholar | Crossref | Medline10. Cragg, GM, Pezzuto, JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract. 2016;25(Suppl 2):41-59. doi:10.1159/000443404
Google Scholar | Crossref | Medline11. Wei, WT, Lin, SZ, Liu, DL, Wang, ZH. The distinct mechanisms of the antitumor activity of emodin in different types of cancer (review). Oncol Rep. 2013;30:2555-2562. doi:10.3892/or.2013.2741
Google Scholar | Crossref | Medline12. Hsu, SC, Chung, JG. Anticancer potential of emodin. BioMedicine. 2012;2:108-116. doi:10.1016/j.biomed.2012.03.003
Google Scholar | Crossref | Medline13. Bai, J, Wu, J, Tang, R, et al. Emodin, a natural anthraquinone, suppresses liver cancer in vitro and in vivo by regulating VEGFR2 and miR-34a. Investig New Drugs. 2020;38:229-245. doi:10.1007/s10637-019-00777-5
Google Scholar | Crossref | Medline14. Höhn, P, Braumann, C, Freiburger, M, Koplin, G, Dubiel, W, Luu, AM. Anti-tumorigenic effects of Emodin and its’ homologue BTB14431 on vascularized colonic cancer in a rat model. Asian Pac J Cancer Prev. 2020;21:205-210. doi:10.31557/APJCP.2020.21.1.205
Google Scholar | Crossref | Medline15. Kim, YS, Lee, YM, Oh, TI, et al. Emodin sensitizes hepatocellular carcinoma cells to the anti-cancer effect of Sorafenib through suppression of cholesterol metabolism. Int J Mol Sci. 2018;19:E3127. doi:10.3390/ijms19103127
Google Scholar | Crossref16. Li, N, Wang, C, Zhang, P, You, S. Emodin inhibits pancreatic cancer EMT and invasion by up-regulating microRNA-1271. Mol Med Rep. 2018;18:3366-3374. doi:10.3892/mmr.2018.9304
Google Scholar | Crossref | Medline17. Gu, J, Cui, CF, Yang, L, Wang, L, Jiang, XH. Emodin inhibits colon cancer cell invasion and migration by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway. Oncol Res. 2019;27:193-202. doi:10.3727/096504018X15150662230295
Google Scholar | Crossref | Medline18. Lin, SZ, Xu, JB, Ji, X, et al. Emodin inhibits angiogenesis in pancreatic cancer by regulating the transforming growth factor-β/drosophila mothers against decapentaplegic pathway and angiogenesis-associated microRNAs. Mol Med Rep. 2015;12:5865-5871. doi:10.3892/mmr.2015.4158
Google Scholar | Crossref | Medline19. Lin, W, Zhong, M, Yin, H, et al. Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo. Oncol Rep. 2016;36:961-967. doi:10.3892/or.2016.4861
Google Scholar | Crossref | Medline20. Dai, G, Ding, K, Cao, Q, et al. Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2. Eur J Pharmacol. 2019;859:172525. doi:10.1016/j.ejphar.2019.172525
Google Scholar | Crossref | Medline21. Hu, L, Cui, R, Liu, H, Wang, F. Emodin and rhein decrease levels of hypoxia-inducible factor-1α in human pancreatic cancer cells and attenuate cancer cachexia in athymic mice carrying these cells. Oncotarget. 2017;8:88008-88020. doi:10.18632/oncotarget.21330
Google Scholar | Crossref | Medline22. Zhang, Y, Pu, W, Bousquenaud, M, et al. Emodin inhibits inflammation, carcinogenesis, and cancer progression in the AOM/DSS model of colitis-associated intestinal tumorigenesis. Front Oncol. 2021;10:564674. doi:10.3389/fonc.2020.564674
Google Scholar | Crossref23. Wang, Z, Chen, H, Chen, J, et al. Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway. Cancer Manag Res. 2019;11:8463-8473. doi:10.2147/CMAR.S221877
Google Scholar | Crossref | Medline24. Guo, H, Liu, F, Yang, S, Xue, T. Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P-glycoprotein and MRPs expression. Oncol Lett. 2020;20:167. doi:10.3892/ol.2020.12030
Google Scholar | Crossref25. Shrimali, D, Shanmugam, MK, Kumar, AP, et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. Cancer Lett. 2013;341:139-149. doi:10.1016/j.canlet.2013.08.023
Google Scholar | Crossref | Medline | ISI26. Dong, X, Fu, J, Yin, X, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res. 2016;30:1207-1218. doi:10.1002/ptr.5631
Google Scholar | Crossref | Medline27. Saunders, IT, Mir, H, Kapur, N, Singh, S. Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. Cancer Cell Int. 2019;19:98. doi:10.1186/s12935-019-0820-3
Google Scholar | Crossref | Medline28. Ma, Q, Ding, Y, Wu, Z, Li, Y. Antitumor effects of emodin in CACO-2 human colon carcinoma cells are mediated via apoptosis, cell cycle arrest and downregulation of PI3K/AKT signalling pathway. J BUON. 2018;23:587-591.
Google Scholar | Medline29. Zhou, RS, Wang, XW, Sun, QF, et al. Anticancer effects of emodin on HepG2 cell: evidence from bioinformatic analysis. Biomed Res Int. 2019;2019:3065818. doi:10.1155/2019/3065818
Google Scholar | Crossref30. Dong, X, Ni, B, Fu, J, et al. Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase-dependent pathway. Oncol Rep. 2018;40:1985-1993. doi:10.3892/or.2018.6620
Google Scholar | Crossref31. Tong, H, Huang, Z, Chen, H, Zhou, B, Liao, Y, Wang, Z. Emodin reverses gemcitabine resistance of pancreatic cancer cell lines through inhibition of IKKβ/NF-κB signaling pathway. Onco Targets Ther. 2020;13:9839-9848. doi:10.2147/OTT.S253691
Google Scholar | Crossref | Medline32. Ma, YS, Weng, SW, Lin, MW, et al. Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: roles of apoptotic cell death and LS1034 tumor xenografts model. Food Chem Toxicol. 2012;50:1271-1278. doi:10.1016/j.fct.2012.01.033
Google Scholar | Crossref | Medline33. Braumann, C, Koplin, G, Geier, C, et al. Dose-dependent role of novel agents emodin and BTB14431 in colonic cancer treatment in rats. Acta Chir Belg. 2017;117:376-384. doi:10.1080/00015458.2017.1341145
Google Scholar | Crossref | Medline34. Yang, K, Jin, MJ, Quan, ZS, Piao, HR. Design and synthesis of novel anti-proliferative emodin derivatives and studies on their cell cycle arrest, apoptosis pathway and migration. Molecules. 2019;24:E884. doi:10.3390/molecules24050884
Google Scholar | Crossref35. Peter, ME. Programmed cell death: apoptosis meets necrosis. Nature. 2011;471:310-312. doi:10.1038/471310a
Google Scholar | Crossref | Medline | ISI36. Leibowitz, B, Yu, J. Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther. 2010;9:417-422. doi:10.4161/cbt.9.6.11392
Google Scholar | Crossref | Medline | ISI37. Zhang, L, He, D, Li, K, et al. Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells. Biomed Pharmacother. 2017;90:222-228. doi:10.1016/j.biopha.2017.03.046
Google Scholar | Crossref | Medline38. Xie, MJ, Ma, YH, Miao, L, et al. Emodin-provoked oxidative stress induces apoptosis in human colon cancer HCT116 cells through a p53-mitochondrial apoptotic pathway. Asian Pac J Cancer Prev. 2014;15:5201-5205. doi:10.7314/apjcp.2014.15.13.5201
Google Scholar | Crossref | Medline39. Cheng, C, Dong, W. Aloe-Emodin induces endoplasmic reticulum stress-dependent apoptosis in colorectal cancer cells. Med Sci Monit. 2018;24:6331-6339. doi:10.12659/MSM.908400
Google Scholar | Crossref | Medline40. Y, Du, Zhang, J, Tao, Z, et al. Aloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways, sub-G1 cell cycle arrest and disruption of mitochondrial membrane potential (ΛΨm). J Buon. 2019;24:746-753.
Google Scholar | Medline41. Cai, FF, Bian, YQ, Wu, R, et al. Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis. Biomed Pharmacother. 2019;114:108863. doi:10.1016/j.biopha.2019.108863
Google Scholar | Crossref42. Li, C, Gao, S, Yang, WS, Jin, GZ, Sun, S. β-Dihydroartemisinin-Emodin promotes apoptosis by activating extrinsic and intrinsic pathways in human liver cancer cells. Ann Clin Lab Sci. 2019;49:281-290.
Google Scholar | Medline43. Zheng, XY, Yang, SM, Zhang, R, Wang, SM, Li, GB, Zhou, SW. Emodin-induced autophagy against cell apoptosis through the PI3K/AKT/mTOR pathway in human hepatocytes. Drug Des Dev Ther. 2019;13:3171-3180. doi:10.2147/DDDT.S204958
Google Scholar | Crossref | Medline44. Srinivas, G, Babykutty, S, Sathiadevan, PP, Srinivas, P. Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent. Med Res Rev. 2007;27:591-608. doi:10.1002/med.20095
Google Scholar | Crossref | Medline45. Redza-Dutordoir, M, Averill-Bates, DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863:2977-2992. doi:10.1016/j.bbamcr.2016.09.012
Google Scholar | Crossref | Medline46. Wang, Y, Luo, Q, He, X, et al. Emodin induces apoptosis of colon cancer cells via induction of autophagy in a ROS-dependent manner. Oncol Res Featuring Preclin Clin Cancer Ther. 2018;26:889-899. doi:10.3727/096504017x15009419625178
Google Scholar